Company news
Optimi Health Corp. news in 2025
Optimi Health Corp.'s news releases, calls and decks from 2025, newest first.
Optimi Health Announces Appointment of New Director
December 18, 2025
Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD
November 26, 2025
Optimi Health Provides Corporate Update
October 21, 2025
Optimi Health's Psilocybin Capsules Selected for Medibank Insurance Program
October 6, 2025
Optimi Announces Public Filing of Registration Statement for Proposed U.S. Initial Public Offering
September 8, 2025
Optimi Health Announces Launch of Psilocybin Capsules in Australia for Treatment-Resistant Depression
September 3, 2025
Optimi Health Announces $3.45 Million Convertible Financing and Extension of Secured Term Loan
July 18, 2025
Optimi Health Completes Largest-to-Date MDMA Export to Australia for PTSD Therapy
May 8, 2025
Optimi Health Obtains U.S. FDA Drug Establishment Registration
May 5, 2025